|
WO2021043127A1
|
|
Chimeric protein
|
|
WO2021037232A1
|
|
Method for editing bcl11a gene in haematopoietic stem/progenitor cells
|
|
WO2020253875A1
|
|
Salts of compound, crystalline forms thereof, preparation method therefor and application thereof
|
|
WO2020253865A1
|
|
Methods for preparing cdk4/6 inhibitor and salt and intermediate thereof
|
|
WO2020253879A1
|
|
Bispecific chimeric antigen receptor
|
|
EP3733676A1
|
|
Compound capable of being used as tumor inhibitor, preparation method therefor, and application thereof
|
|
CN110724187A
|
|
Recombinant engineering bacterium for efficiently expressing liraglutide precursor and application thereof
|
|
CN109987762A
|
|
The method for handling the ammonia nitrogen waste water that evaporation urea generates in peptide production process
|
|
CN109957001A
|
|
The preparation method of sweet insulin lispro crystallization
|
|
CN106810536A
|
|
A kind of kinases inhibitor and preparation method thereof and medical usage
|
|
CN106608879A
|
|
Protein kinase inhibitor and its preparation method and medical application
|
|
CN106478805A
|
|
A kind of preparation method of GLP-1 derivant
|
|
CN103966191A
|
|
Preparation method of recombinant bovine trypsin
|
|
WO2012152175A1
|
|
Preparation method for insulin glargine crystal
|
